鱼腥草提取物对肺炎支原体感染大鼠的抗炎作用及其作用机制

Anti-inflammatory effect of Houttuynia extract on rats with Mycoplasma pneumoniae infection and mechanisms of action

  • 摘要:
    目的 对肺炎支原体感染大鼠进行鱼腥草提取物治疗, 对其所产生抗炎功效及作用机制进行分析。
    方法 SPF级Wistar雄性大鼠分为空白组、肺炎支原体感染模型组、鱼腥草提取物低剂量组和高剂量组各9只。空白组、模型组只进行生理盐水灌胃, 低剂量组和高剂量组给予鱼腥草提取物125 mg/kg、500 mg/kg灌胃, 持续7 d后检测外周血转化生长因子-β(TGF-β)、涎液化糖链抗原-6(KL-6)、表面活性蛋白D(SP-D)、炎症因子及Toll样受体4(TLR4)、髓样分化因子88(MyD88)、核因子κB(NF-κB)mRNA相对表达量, 免疫印迹法检测肺组织中TLR4、MyD88、NF-κB蛋白表达。
    结果 与空白组比较, 模型组、鱼腥草提取物低剂量组、高剂量组TGF-β、KL-6、SP-D、IL-13、TNF-α水平、TLR4、MyD88、NF-κB mRNA表达量、TLR4、MyD88、NF-κB蛋白表达量均升高, IL-12水平降低(P<0.05);与模型组、低剂量组比较, 高剂量组TGF-β、KL-6、SP-D、IL-13、TNF-α水平、TLR4、MyD88、NF-κB mRNA表达量、TLR4、MyD88、NF-κB蛋白表达量均降低, IL-12水平升高(P<0.05)。
    结论 通过鱼腥草提取物对肺炎支原体感染大鼠进行治疗干预, 以改善局部乃至支气管和肺组织炎症反应, 达到较好的干预效果。

     

    Abstract:
    OBJECTIVE To observe the anti-inflammatory effect of Houttuynia extract on rats with Mycoplasma pneumoniae infection and analyze the mechanisms of action.
    METHODS The Wistar rats of SPF grade were divided into the blank group, the M.pneumoniae infection model group, the low-dose houttuynia extract group and the high-dose houttuynia extract group, with 9 rats in each group. The blank group and the model group were only treated with normal saline for gavage, the low-dose group and the high-dose group were respectively treated with 125 mg/kg and 500 mg/kg of houttuynia extract for gavage. The levels of peripheral blood transforming growth factor-β(TGF-β), Krebs Von den Lungen-6 (KL-6), surface active protein D (SP-D), inflammatory factors and the relative expression levels of Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88) and nuclear factor κB (NF-κB) mRNA were detected after the treatments for 7 consecutive days; the expression levels of TLR4, MyD88 and NF-κB proteins in lung tissues were detected by Western Blot.
    RESULTS The levels of TGF-β, KL-6, SP-D, IL-13, TNF-α, the expression levels of TLR4, MyD88, NF-κB mRNA, and the expression levels of TLR4, MyD88 and NF-κB proteins were higher in the model group, the low-dose houttuynia extract group and the high-dose houttuynia extract group than in the blank group, while the IL-12 level was lower in the model group, the low-dose houttuynia extract group and the high-dose houttuynia extract group than in the blank group (P < 0.05). The levels of TGF-β, KL-6, SP-D, IL-13, TNF-α, the expression levels of TLR4, MyD88, NF-κB mRNA, and the expression levels of TLR4, MyD88 and NF-κB proteins were lower in the high-dose houttuynia extract group than in the model group and the low-dose houttuynia extract group; the IL-12 level of the high-dose houttuynia extract group was higher than that of the model group and the low-dose houttuynia extract group(P < 0.05).
    CONCLUSION As a treatment intervention, Houttuynia extract may alleviate the local inflammatory response or even the inflammatory responses in bronchia and lung tissues so as to achieve favorable intervention effect.

     

/

返回文章
返回